{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:47:51Z","timestamp":1791301671877,"version":"4.1.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:p>The head and neck is the site of a wide and sometimes bewildering array of neuroendocrine (NE) tumors. Although recognition of NE differentiation may be necessary for appropriate tumor classification and treatment, traditional NE markers such as synaptophysin, chromogranin, and CD56 are not always sufficiently sensitive or specific to make this distinction. Insulinoma-associated protein 1 (INSM1) is a novel transcription factor that has recently demonstrated excellent sensitivity and specificity for NE differentiation in various anatomic sites, but has not yet been extensively evaluated in tumors of the head and neck. We performed INSM1 immunohistochemistry on NE tumors (n=97) and non-NE tumors (n=626) across all histologic grades and anatomic subsites of the head and neck. INSM1 was positive in all types of head and neck NE tumors evaluated here (99.0% sensitivity), including middle ear adenoma, pituitary adenoma, paraganglioma, medullary thyroid carcinoma, olfactory neuroblastoma, small cell carcinoma, large cell NE carcinoma, and sinonasal teratocarcinosarcoma. Notably, it was positive in the vast majority of high-grade NE malignancies (95.8% sensitivity). INSM1 also was negative in almost all non-NE tumors (97.6% specificity) with the highest rates of reactivity in alveolar rhabdomyosarcoma and SWI\/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily B, member 1 (SMARCB1)-deficient sinonasal carcinoma. These findings confirm that INSM1 may be used as a standalone first-line marker of NE differentiation for tumors of the head and neck.<\/jats:p>","DOI":"10.1097\/pas.0000000000001037","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T15:40:32Z","timestamp":1518536432000},"page":"665-671","source":"Crossref","is-referenced-by-count":146,"title":["INSM1 is a Sensitive and Specific Marker of Neuroendocrine Differentiation in Head and Neck Tumors"],"prefix":"10.1097","volume":"42","author":[{"given":"Lisa M.","family":"Rooper","sequence":"first","affiliation":[{"name":"Department of Pathology, The Johns Hopkins Hospital, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin A.","family":"Bishop","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Westra","sequence":"additional","affiliation":[{"name":"Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"78","DOI":"10.6004\/jnccn.2015.0011","article-title":"Neuroendocrine tumors, version 1.2015","volume":"13","author":"Kulke","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00405-011-1666-z","article-title":"The evolving management of laryngeal neuroendocrine carcinomas","volume":"268","author":"Ferlito","year":"2011","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1177\/0194599815594386","article-title":"Laryngeal neuroendocrine carcinoma: a population-based analysis of incidence and survival","volume":"153","author":"Ghosh","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/lary.21790","article-title":"Terminology and classification of neuroendocrine neoplasms of the larynx","volume":"121","author":"Lewis","year":"2011","journal-title":"Laryngoscope"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12105-016-0696-7","article-title":"Neuroendocrine neoplasms of the sinonasal tract: neuroendocrine carcinomas and olfactory neuroblastoma","volume":"10","author":"Shah","year":"2016","journal-title":"Head Neck Pathol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"issue":"suppl 1","key":"R7-20230922","first-page":"E2259","article-title":"Neuroendocrine neoplasms of the sinonasal region","volume":"38","author":"Bell","year":"2016","journal-title":"Head Neck"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000276222","article-title":"Contribution of immunohistochemistry in the diagnosis of neuroendocrine neoplasms of the larynx","volume":"53","author":"Ferlito","year":"1991","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0046-8177(95)90169-8","article-title":"Is esthesioneuroblastoma a peripheral neuroectodermal tumor?","volume":"26","author":"Nelson","year":"1995","journal-title":"Hum Pathol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1080\/00016480410016540","article-title":"Immunohistochemical studies in support of a diagnosis of small cell neuroendocrine carcinoma of the larynx","volume":"124","author":"Rinaldo","year":"2004","journal-title":"Acta Otolaryngol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.humpath.2007.08.019","article-title":"Utility of high molecular weight cytokeratins, but not p63, in the differential diagnosis of neuroendocrine and basaloid carcinomas of the head and neck","volume":"39","author":"Serrano","year":"2008","journal-title":"Hum Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1017\/S0022215100113015","article-title":"Neuro-endocrine tumours of the head and neck","volume":"104","author":"Soussi","year":"1990","journal-title":"J Laryngol Otol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/modpathol.2008.86","article-title":"Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall","volume":"21","author":"Bahrami","year":"2008","journal-title":"Mod Pathol"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/PAI.0b013e3181ee8dcb","article-title":"Immunophenotypic heterogeneity of primary sinonasal melanoma with aberrant expression of neuroendocrine markers and calponin","volume":"19","author":"Lee","year":"2011","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1385\/EP:12:3:291","article-title":"Neuroendocrine marker expression in thyroid epithelial tumors","volume":"12","author":"Satoh","year":"2001","journal-title":"Endocr Pathol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1017\/S0022215112002265","article-title":"Neuroendocrine differentiation in head and neck squamous cell carcinoma","volume":"126","author":"Schartinger","year":"2012","journal-title":"J Laryngol Otol"},{"key":"R17-20230922","article-title":"Sinonasal tract alveolar rhabdomyosarcoma in adults: a clinicopathologic and immunophenotypic study of fifty-two cases with emphasis on epithelial immunoreactivity","author":"Thompson","year":"2017","journal-title":"Head Neck Pathol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1097\/PAS.0000000000000460","article-title":"Adamantinoma-like Ewing family tumors of the head and neck: a pitfall in the differential diagnosis of basaloid and myoepithelial carcinomas","volume":"39","author":"Bishop","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/PAS.0000000000000285","article-title":"SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract","volume":"38","author":"Bishop","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/PAS.0000000000000797","article-title":"SMARCB1 (INI-1)-deficient sinonasal carcinoma: a series of 39 cases expanding the morphologic and clinicopathologic spectrum of a recently described entity","volume":"41","author":"Agaimy","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12022-003-0017-z","article-title":"Calcitonin immunoreactivity in neoplastic and hyperplastic parathyroid glands: an immunohistochemical study","volume":"14","author":"Khan","year":"2003","journal-title":"Endocr Pathol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF02739826","article-title":"Immunocytochemical staining patterns for parathyroid hormone and chromogranin in parathyroid hyperplasia, adenoma, and carcinoma","volume":"10","author":"Tomita","year":"1999","journal-title":"Endocr Pathol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/nar\/30.4.1038","article-title":"Neuroendocrine differentiation factor, IA-1, is a transcriptional repressor and contains a specific DNA-binding domain: identification of consensus IA-1 binding sequence","volume":"30","author":"Breslin","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1016\/j.ajpath.2015.08.018","article-title":"Insulinoma-associated protein 1 is a crucial regulator of neuroendocrine differentiation in lung cancer","volume":"185","author":"Fujino","year":"2015","journal-title":"Am J Pathol"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1101\/gad.381806","article-title":"The zinc-finger factor INSM1 (IA-1) is essential for the development of pancreatic beta cells and intestinal endocrine cells","volume":"20","author":"Gierl","year":"2006","journal-title":"Genes Dev"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"15252","DOI":"10.1016\/S0021-9258(18)42173-4","article-title":"A novel human insulinoma-associated cDNA, IA-1, encodes a protein with \u201czinc-finger\u201d DNA-binding motifs","volume":"267","author":"Goto","year":"1992","journal-title":"J Biol Chem"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1096\/fj.08-125971","article-title":"Structure, expression, and biological function of INSM1 transcription factor in neuroendocrine differentiation","volume":"23","author":"Lan","year":"2009","journal-title":"FASEB J"},{"key":"R28-20230922","first-page":"4169","article-title":"IA-1, a new marker for neuroendocrine differentiation in human lung cancer cell lines","volume":"53","author":"Lan","year":"1993","journal-title":"Cancer Res"},{"key":"R29-20230922","first-page":"567","article-title":"Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer","volume":"29","author":"Taniwaki","year":"2006","journal-title":"Int J Oncol"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1749-8104-6-6","article-title":"INSM1 promotes the transition of olfactory progenitors from apical and proliferative to basal, terminally dividing and neuronogenic","volume":"6","author":"Rosenbaum","year":"2011","journal-title":"Neural Dev"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1097\/PAS.0000000000000916","article-title":"INSM1 demonstrates superior performance to the individual and combined use of synaptophysin, chromogranin and CD56 for diagnosing neuroendocrine tumors of the thoracic cavity","volume":"41","author":"Rooper","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12105-013-0442-3","article-title":"GATA3 immunohistochemical expression in salivary gland neoplasms","volume":"7","author":"Schwartz","year":"2013","journal-title":"Head Neck Pathol"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/PAS.0b013e318254ce54","article-title":"NUT midline carcinomas of the sinonasal tract","volume":"36","author":"Bishop","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1309\/AJCPGZWXXBSNL4VD","article-title":"INSM1: a novel immunohistochemical and molecular marker for neuroendocrine and neuroepithelial neoplasms","volume":"144","author":"Rosenbaum","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"R35-20230922","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ygyno.2016.11.020","article-title":"A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: Analysis of 37 cases","volume":"144","author":"Kuji","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R36-20230922","article-title":"Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor","author":"Tanigawa","year":"2017","journal-title":"Med Mol Morphol"},{"key":"R37-20230922","article-title":"Squamous and neuroendocrine specific immunohistochemical markers in head and neck squamous cell carcinoma: a tissue microarray study","author":"Lewis","year":"2017","journal-title":"Head Neck Pathol"},{"key":"R38-20230922","first-page":"279","article-title":"Neuroendocrine differentiation in a case of acinic cell carcinoma of the parotid gland","volume":"40","author":"Ito","year":"1990","journal-title":"Acta Pathol Jpn"},{"key":"R39-20230922","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12105-009-0114-5","article-title":"Acinic cell carcinoma with extensive neuroendocrine differentiation: a diagnostic challenge","volume":"3","author":"Roy","year":"2009","journal-title":"Head Neck Pathol"},{"key":"R40-20230922","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.path.2016.10.005","article-title":"Sinonasal small round blue cell tumors: an immunohistochemical approach","volume":"10","author":"Rooper","year":"2017","journal-title":"Surg Pathol Clin"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201805000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T18:37:07Z","timestamp":1695407827000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201805000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001037","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}